According to market research study published by Gen Consulting Company, the global artificial insemination market stood at around USD 1,847 million in 2021 and is projected to rise to a worth of USD 3,104 million by 2028 end, thereby garnering a CAGR of 7.7% during 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global artificial insemination market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the artificial insemination industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, source, end user, and region. The global market for artificial insemination can be segmented by type: intracervical, intratubal, intrauterine. Artificial insemination market is further segmented by source: AID, AIH. Based on end user, the artificial insemination market is segmented into: fertility centers, home, hospitals & clinics. On the basis of region, the artificial insemination market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By type:
– intracervical
– intratubal
– intrauterine
By source:
– AID
– AIH
By end user:
– fertility centers
– home
– hospitals & clinics
By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
The report has also analysed the competitive landscape of the global artificial insemination market with some of the key players being FUJIFILM Irvine Scientific, Inc., Genea Limited, Pride Angel Ltd., Rinovum Women’s Health, LLC, Vitrolife AB, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global artificial insemination market.
– To classify and forecast the global artificial insemination market based on type, source, end user, region.
– To identify drivers and challenges for the global artificial insemination market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global artificial insemination market.
– To identify and analyze the profile of leading players operating in the global artificial insemination market.
Why Choose This Report
– Gain a reliable outlook of the global artificial insemination market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 7.7% |
| Pages | 85 |
| Key Players | FUJIFILM Irvine Scientific Inc., Genea Limited, Pride Angel Ltd., Rinovum Women's Health LLC, Vitrolife AB |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
